306 related articles for article (PubMed ID: 37509540)
1. The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems.
Aceves-Franco LA; Sanchez-Aguilar OE; Barragan-Arias AR; Ponce-Gallegos MA; Navarro-Partida J; Santos A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509540
[TBL] [Abstract][Full Text] [Related]
2. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
5. Intraocular corticosteroids for posterior segment disease: 2012 update.
Kiernan DF; Mieler WF
Expert Opin Pharmacother; 2012 Aug; 13(12):1679-94. PubMed ID: 22783878
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
7. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
Jonas JB; Schlichtenbrede F
Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
Cheng T; Li J; Cheng Y; Zhang X; Qu Y
Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
[TBL] [Abstract][Full Text] [Related]
9. Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema.
Navarro-Partida J; Altamirano-Vallejo JC; Gonzalez-De la Rosa A; Armendariz-Borunda J; Castro-Castaneda CR; Santos A
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801366
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
13. Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
Fung S; Syed YY
Drugs; 2022 Sep; 82(13):1403-1410. PubMed ID: 36018461
[TBL] [Abstract][Full Text] [Related]
14. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review.
José-Vieira R; Ferreira A; Menéres P; Sousa-Pinto B; Figueira L
Surv Ophthalmol; 2022; 67(4):991-1013. PubMed ID: 34896190
[TBL] [Abstract][Full Text] [Related]
17. Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Budde WM; Degenring RF
Eur J Ophthalmol; 2005; 15(3):329-35. PubMed ID: 15945000
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions.
Roth DB; Cukras C; Radhakrishnan R; Feuer WJ; Yarian DL; Green SN; Wheatley HM; Prenner J
Ophthalmic Surg Lasers Imaging; 2008; 39(6):446-54. PubMed ID: 19065973
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O
Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781
[TBL] [Abstract][Full Text] [Related]
20. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O
J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
